Rare diseases
Investigational molecules
Locations
Ul. Zamiejska 17, 03-580 Warsaw, Poland
Niepubliczny Zakład Opieki Zdrowotnej Vivamed Jadwiga Miecz in Warsaw, Poland specialises in clinical trials of conditions such as Crohn's disease, Colitis ulcerative, and other specialisations. This site conducts important research.
The medical center is at the forefront of gastroenterology research, with a particular focus on ulcerative colitis. This chronic inflammatory bowel disease is characterized by inflammation and ulcers in the digestive tract, primarily affecting the colon and rectum.
Through rigorous clinical trials, the center is advancing the understanding and treatment of ulcerative colitis, aiming to improve patient outcomes by achieving clinical remission and enhancing quality of life.
Clinical trials currently enrolling participants at this site.
A study testing XmAb942 compared to placebo in adults with moderate-to-severe active ulcerative colitis
PolandStudy of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease
PolandStudy on the Effectiveness and Safety of RO7790121 for Patients with Moderate to Severe Crohn's Disease
PolandStudy on the Effectiveness and Safety of Obefazimod for Patients with Moderate to Severe Crohn's Disease After Inadequate Response to Other Treatments
PolandLong-term safety study of tulisokibart in adults with Crohn's disease or ulcerative colitis
PolandStudy of MT-501 in patients with active Crohn's Disease or Ulcerative Colitis: A Phase 2 safety and effectiveness trial
PolandStudy on GS-1427 for Adults with Moderate to Severe Ulcerative Colitis
PolandStudy on the Effectiveness and Safety of Guselkumab and Ustekinumab for Patients with Moderate to Severe Crohn's Disease
PolandStudy on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults
PolandA study to evaluate the long-term safety and effectiveness of balinatunfib in adults with Crohn's disease or ulcerative colitis
PolandStudy on the Effectiveness and Safety of SAR441566 for Adults with Moderate-to-Severe Ulcerative Colitis
PolandStudy on Guselkumab for Patients with Moderate to Severe Crohn's Disease
PolandMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
